title: Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT.
authors.affiliation: Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: Hughes
authors.affiliation: AstraZeneca, Cambridge, UK.
authors.forename: Donal
authors.initials: D
authors.lastname: Landers
authors.affiliation: Sarah Cannon Research Institute, London, UK.|University College London, London, UK.
authors.forename: Hendrik-Tobias
authors.initials: HT
authors.lastname: Arkenau
authors.affiliation: AstraZeneca, Cambridge, UK.
authors.forename: Saj
authors.initials: S
authors.lastname: Shah
authors.affiliation: Consumer Forum, National Cancer Research Institute, London, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Stephens
authors.affiliation: AstraZeneca, Cambridge, UK.
authors.forename: Amrik
authors.initials: A
authors.lastname: Mahal
authors.affiliation: Sarah Cannon Research Institute, London, UK.
authors.forename: Matthew
authors.initials: M
authors.lastname: Simmons
authors.affiliation: Sarah Cannon Research Institute, London, UK.|University College London, London, UK.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Lemech
authors.affiliation: AstraZeneca, Cambridge, UK. Jenny.Royle@cruk.manchester.ac.uk.|Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Jenny.Royle@cruk.manchester.ac.uk.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Royle